Stocksigma LogoStocksigma Logo

Lupin Secures U.S. FDA Approval for Phytonadione Injectable Emulsion Prefilled Syringe

Lupin Limited received U.S. FDA approval on 8th Oct'26 for its ANDA covering Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL single-dose prefilled

Lupin Secures U.S. FDA Approval for Phytonadione Injectable Emulsion Prefilled Syringe

Lupin Ltd 路 Press Release 路 09 Oct 2026, 2:28 am

Lupin Secures U.S. FDA Approval for Phytonadione Injectable Emulsion Prefilled Syringe Lupin Limited received U.S. FDA approval on 8th Oct'26 for its ANDA covering Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL single-dose prefilled syringe. The generic is bioequivalent to International Medication Systems' reference listed drug and is indicated for the treatment and prophylaxis of hypoprothrombinemia and vitamin K-deficiency. According to IQVIA MAT Aug'26 data, Phytonadione Injectable Emulsion generated estimated annual sales of USD 52.3 million in the U.S. market, expanding Lupin鈥檚 injectable portfolio.

Original exchange filing (PDF)

More announcements from Lupin Ltd

All Lupin Ltd announcements